Browsing: News

IMbrella A, an extension of the Phase III IMpower133 study, demonstrates the potential for a durable overall survival benefit with Tecentriq plus chemotherapy in extensive-stage small cell lung cancer (ES-SCLC)
IMbrella A data build on the previously reported IMpower133 trial, which was the first clinically meaningful advance in the treatment of ES-SCLC in more than twenty years

Log In or Register as a healthcare professional to read the full article.

Celebrated globally on this day, 17th September, World Patient Safety Day 2023 has a specific focus: “Elevate the Voice of Patients!”. This is the fifth annual World Patient Safety Day. The World Health Organisation (WHO) has underlined the critical role that patients, families, and caregivers play in ensuring safer healthcare. The theme holds significant implications for Asia, given its complex and diverse healthcare landscape.